Trying to separate three different claims about thymosin alpha-1: that it is the right molecule, that it is the right dose, and that it does something useful.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took two years to be sure.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
Injection site reactions are trivial until they are not, and a fresh needling technique removes half of them.
How do you separate the compound effect from the routine around it?
If it needs three other compounds to notice, you have not tested the first one.
Sterility is the part people wave through and it is the part that actually bites.
Reconstitution arithmetic is only half the problem. The other half is what was in the vial.
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.
Name the active ingredient, not just the brand. It makes these threads searchable years later.
Baseline first. Currently on thymosin alpha-1 myself.
Stupid question: how do you know whether what is in the vial matches the label at all?
Most of what is called evidence here is one person, one vial, one month.
Sterility is the part people wave through and it is the part that actually bites.
Stupid question: how do you know whether what is in the vial matches the label at all?
Same here.
Same here.
Narrow conclusion.
Where does the human data stop and the extrapolation begin? That is the whole thread.